Radiation Therapy $140 million revolver priced at Libor plus 550 bps

By Sara Rosenberg

New York, May 14 - Radiation Therapy Services Inc.'s $140 million revolving credit facility due Oct. 15, 2016 is initially priced at Libor plus 550 basis points with a 100 bps unused fee, according to an 8-K filed with the Securities and Exchange Commission on Monday.

Pricing can range from Libor plus 500 bps to 575 bps and the unused fee can range from 50 bps to 100 bps, based on leverage.

Wells Fargo Securities LLC, SunTrust Robinson Humphrey Inc. and Morgan Stanley Senior Funding Inc. acted as the lead arrangers and bookrunners on the deal that was completed on May 10.

There is a $10 million accordion feature.

Covenants include a first-lien leverage ratio.

Proceeds are available for general corporate purposes.

Radiation Therapy is a Fort Myers, Fla.-based provider of advanced radiation therapy and other clinical services to cancer patients.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.